Skip to main content

Original Research

Original Research, Rosacea, Dermatology
Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study
Todd Williamson, PhD, MSc, Wendy Y. Cheng, MPhil, MPH, Nora McCormick, MSc, Francis Vekeman, MA
Todd Williamson, PhD, MSc; Wendy Y. Cheng, MPhil, MPH; Nora McCormick, MSc; Francis Vekeman, MA
Stakeholder Perspective
There’s Room for Improvement in Rosacea Treatment
Gary M. Owens, MD
by Gary M. Owens, MD
Read More
Original Research
Newly Diagnosed Hepatitis C in the US Commercially Insured Population Before and After the 2012 Implementation of Expanded Screening Guidelines
Bruce S. Pyenson, FSA, MAAA, Gabriela Dieguez, FSA, MAAA, Christine Ferro, CHFP, Maushumi Mavinkurve, MPH, Yuri Sanchez Gonzalez, PhD
Bruce S. Pyenson, FSA, MAAA; Gabriela Dieguez, FSA, MAAA; Christine Ferro; Maushumi Mavinkurve, MPH; Yuri Sanchez Gonzalez, PhD
Stakeholder Perspective
Importance of Health Outcomes Research for the Treatment of Hepatitis C Infection
Jack E. Fincham, PhD, RPh
by Jack E. Fincham, PhD, RPh
Read More
Original Research, Practice Management
Temporal Trends in Survival and Healthcare Costs in Patients with Multiple Myeloma in the United States
Eric M. Maiese, MHS, PhD, Kristin A. Evans, PhD, Bong-Chul Chu, PhD, Debra E. Irwin, MSPH, PhD
Eric M. Maiese, MHS, PhD; Kristin A. Evans, PhD; Bong-Chul Chu, PhD; Debra E. Irwin, MSPH, PhD
Stakeholder Perspective
Improved Clinical Outcomes with Newer Multiple Myeloma Therapies Associated with Increased Resource Utilization and Financial Burden
Matthew Mitchell, PharmD, MBA, FAMCP
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Original Research
Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States
J. Douglas Thornton, PhD, PharmD, BCPS, Nilanjana Dwibedi, BPharm, MBA, PhD, Virginia Scott, PhD, Charles D. Ponte, PharmD, Douglas Ziedonis, MD, Nethra Sambamoorthi, PhD, Usha Sambamoorthi, PhD
J. Douglas Thornton, PharmD, PhD; Nilanjana Dwibedi, PhD; Virginia Scott, PhD; Charles D. Ponte, PharmD; Douglas Ziedonis, MD; Nethra Sambamoorthi, PhD; Usha Sambamoorthi, PhD
Stakeholder Perspective
Addiction Prediction: Preventing Iatrogenic Opioid Dependence
Albert Tzeel, MD, MHSA, CPE, FAAPL
by Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
Press Releases, Original Research
Researchers Identify 4 Predictors of Transition to Chronic Opioid Use Based on Readily Available Opioid Regimen and Patient Factors
Read More
Original Research
Prospective Bundled Payments in a Changing Environment: The Experience of a Self-Funded, State-Sponsored Plan
Frank H. Lawler, MD, MSPH, Frank R. Wilson, CPA, G. Keith Smith, MD, Lynn V. Mitchell, MD, MPH
Frank H. Lawler, MD, MSPH; Frank R. Wilson, CPA; G. Keith Smith, MD; Lynn V. Mitchell, MD, MPH
Stakeholder Perspective
Oklahoma Benefits Program Setting an Example: A Cost-Effective Bundled Payments Option for State Employees
James T. Kenney, RPh, MBA
by James T. Kenney, RPh, MBA
Read More
Original Research, Practice Management
The Effects of a Sitagliptin Formulary Restriction Program on Diabetes Medication Use
Yuexin Tang, PhD, Xingyue Huang, PhD, Jinan Liu, PhD, R. Ravi Shankar, MD, Michael L. Ganz, PhD, Swapnil Rajpathak, MD, DrPH
Yuexin Tang, PhD; Xingyue Huang, PhD; Jinan Liu, PhD; R. Ravi Shankar MD; Michael L. Ganz, PhD; Swapnil Rajpathak, MD, DrPH
Stakeholder Perspective
Impact of Step Therapy Restrictions in Diabetes Care
Quang T. Nguyen, DO, FACP, FACE, FTOS
by Quang T. Nguyen, DO, FACE, FTOS
Read More
Original Research
Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor
JoAnne Foody, MD, Robin S. Turpin, PhD, Beni A. Tidwell, BS, Debra Lawrence, PhD, Kathy L. Schulman, MS
JoAnne Foody, MD; Robin S. Turpin, PhD; Beni A. Tidwell, BS; Debra Lawrence, PhD; Kathy L. Schulman, MS
Stakeholder Perspective
The Growing Role of Real-World Evidence in Clinical Decision-Making
Gary M. Owens, MD
by Gary M. Owens, MD
Read More
Original Research, Practice Management
Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors
Rajeev Ayyagari, PhD, Maureen Neary, PhD, MS, Shang Li, MS, Ariel Rokito, BS, Hongbo Yang, PhD, Jipan Xie, MD, PhD, Al B. Benson III, MD, FACP, FASCO
Rajeev Ayyagari, PhD; Maureen Neary, PhD, MS; Shang Li, MS; Ariel Rokito, BS; Hongbo Yang, PhD; Jipan Xie, MD, PhD; Al B. Benson III, MD, FACP, FASCO
Read More
Original Research, Practice Management
The Cost of Hematopoietic Stem-Cell Transplantation in the United States
Michael S. Broder, MD, MSHS, Tiffany P. Quock, MS, PhD, Eunice Chang, PhD, Sheila R. Reddy, PhD, RPh, Rajni Agarwal-Hashmi, MD, Sally Arai, MD, Kathleen F. Villa, MS
Michael S. Broder, MD, MSHS; Tiffany P. Quock, PhD, MS; Eunice Chang, PhD; Sheila R. Reddy, PhD, RPh; Rajni Agarwal-Hashmi, MD; Sally Arai, MD; Kathleen F. Villa, MS
Stakeholder Perspective
More Data Analysis Is Needed to Improve Outcomes, Lower Costs, and Maximize Appropriate Resource Use
James T. Kenney, RPh, MBA
by James T. Kenney, RPh, MBA
Read More
Page 9 of 21
Results 81 - 90 of 209